$XBIT
XBiotech Inc

2024 Q2 Form 10-Q Financial Statement

#000117184324002746 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $915.0K
YoY Change -30.37%
% of Gross Profit
Research & Development $12.98M $9.825M $6.230M
YoY Change 15.25% 57.7% -8.62%
% of Gross Profit
Depreciation & Amortization $435.0K $432.0K $443.0K
YoY Change -1.14% -2.48% -37.61%
% of Gross Profit
Operating Expenses $14.97M $10.85M $7.145M
YoY Change 12.88% 51.9% -12.14%
Operating Profit -$14.97M -$10.85M -$7.145M
YoY Change 12.88% 51.9% -8.92%
Interest Expense $3.162M
YoY Change 127.32%
% of Operating Profit
Other Income/Expense, Net $1.935M $876.0K $3.292M
YoY Change -57.82% -73.39% 136.66%
Pretax Income -$13.03M -$9.977M -$3.853M
YoY Change 50.28% 158.94% -40.3%
Income Tax -$25.00K $25.00K -$37.00K
% Of Pretax Income
Net Earnings -$13.01M -$10.00M -$3.816M
YoY Change 48.78% 162.11% -29.27%
Net Earnings / Revenue
Basic Earnings Per Share -$0.43 -$0.33 -$0.13
Diluted Earnings Per Share -$0.13
COMMON SHARES
Basic Shares Outstanding 30.46M 30.45M 30.44M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $188.5M $201.0M $212.7M
YoY Change -7.94% -5.47% -8.26%
Cash & Equivalents $188.5M $201.0M $152.5M
Short-Term Investments $60.18M
Other Short-Term Assets $1.116M $1.072M $703.0K
YoY Change 24.0% 52.49% 11.23%
Inventory
Prepaid Expenses
Receivables $870.0K $870.0K $2.371M
Other Receivables $123.0K $75.00K $548.0K
Total Short-Term Assets $190.6M $203.1M $216.3M
YoY Change -9.01% -6.12% -10.99%
LONG-TERM ASSETS
Property, Plant & Equipment $24.92M $24.80M $25.84M
YoY Change -2.76% -4.01% -7.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.92M $24.80M $25.84M
YoY Change -2.76% -4.01% -7.14%
TOTAL ASSETS
Total Short-Term Assets $190.6M $203.1M $216.3M
Total Long-Term Assets $24.92M $24.80M $25.84M
Total Assets $215.6M $227.9M $242.1M
YoY Change -8.33% -5.89% -10.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.704M $2.607M $1.357M
YoY Change -6.17% 92.11% 2.57%
Accrued Expenses $5.348M $4.194M $2.206M
YoY Change 103.04% 90.12% 40.69%
Deferred Revenue
YoY Change
Short-Term Debt $10.00M $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00M
YoY Change
Total Short-Term Liabilities $17.14M $16.88M $3.618M
YoY Change 285.06% 366.67% 25.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.719M $1.694M $1.598M
YoY Change 7.44% 6.01% 8.05%
Total Long-Term Liabilities $1.719M $1.694M $1.598M
YoY Change 7.44% 6.01% 8.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.14M $16.88M $3.618M
Total Long-Term Liabilities $1.719M $1.694M $1.598M
Total Liabilities $18.85M $18.58M $5.216M
YoY Change 210.46% 256.17% -0.51%
SHAREHOLDERS EQUITY
Retained Earnings -$75.31M -$62.31M -$31.57M
YoY Change 86.85% 97.4% 12836.48%
Common Stock $272.0M $271.6M $268.0M
YoY Change 1.15% 1.33% 1.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $196.7M $209.3M $236.9M
YoY Change
Total Liabilities & Shareholders Equity $215.6M $227.9M $242.1M
YoY Change -8.33% -5.89% -10.59%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$13.01M -$10.00M -$3.816M
YoY Change 48.78% 162.11% -29.27%
Depreciation, Depletion And Amortization $435.0K $432.0K $443.0K
YoY Change -1.14% -2.48% -37.61%
Cash From Operating Activities -$11.38M -$7.202M -$4.808M
YoY Change 26.4% 49.79% -6.15%
INVESTING ACTIVITIES
Capital Expenditures $627.0K $255.0K $6.000K
YoY Change 213.5% 4150.0% -96.27%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$627.0K -$255.0K -$6.000K
YoY Change 213.5% 4150.0% -96.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 48.00K $10.06M $0.00
YoY Change -580.0%
NET CHANGE
Cash From Operating Activities -11.38M -$7.202M -$4.808M
Cash From Investing Activities -627.0K -$255.0K -$6.000K
Cash From Financing Activities 48.00K $10.06M $0.00
Net Change In Cash -11.96M $1.016M -$4.822M
YoY Change 29.8% -121.07% -6.59%
FREE CASH FLOW
Cash From Operating Activities -$11.38M -$7.202M -$4.808M
Capital Expenditures $627.0K $255.0K $6.000K
Free Cash Flow -$12.00M -$7.457M -$4.814M
YoY Change 30.47% 54.9% -8.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002000 usd
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001626878
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
10853000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7145000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10853000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7145000 usd
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2658000 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2779000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1582000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
383000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
876000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3292000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9977000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3853000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3816000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30443973
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30439275
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3816000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-386000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10002000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4202000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
218846000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10002000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
381000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
209280000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240402000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3816000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-386000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
705000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
236905000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3816000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
432000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
443000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1582000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
383000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
381000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
705000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
10000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1155000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
312000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
103000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1064000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
694000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
602000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
22000 usd
CY2024Q1 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
0 usd
CY2023Q1 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
-59000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7202000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4808000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
255000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-255000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10055000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 xbit Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations1
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations1
-1582000 usd
CY2023Q1 xbit Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations1
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations1
-8000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1016000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4822000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
200023000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
157306000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
201039000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
152484000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
82000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201000000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 31pt; text-align: left;">The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported values of amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
381000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
705000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.91
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.84
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1600000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24802000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24897000 usd
CY2023Q2 xbit Treasury Stock Shares Offered To Be Purchased Value
TreasuryStockSharesOfferedToBePurchasedValue
80000000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3561
CY2023Q2 xbit Stock Repurchased During Period Price Per Share
StockRepurchasedDuringPeriodPricePerShare
4
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
14000 usd
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1250
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.84
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4800000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13917
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
55000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5039518
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
23000
CY2024Q1 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
13917
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
614750
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4433851
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1100000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009 pure

Files In Submission

Name View Source Status
0001171843-24-002746-index-headers.html Edgar Link pending
0001171843-24-002746-index.html Edgar Link pending
0001171843-24-002746.txt Edgar Link pending
0001171843-24-002746-xbrl.zip Edgar Link pending
ex_665418.htm Edgar Link pending
ex_665419.htm Edgar Link pending
ex_665420.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xbit-20240331.xsd Edgar Link pending
xbit20240331_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
xbit-20240331_lab.xml Edgar Link unprocessable
xbit-20240331_cal.xml Edgar Link unprocessable
xbit-20240331_pre.xml Edgar Link unprocessable
xbit-20240331_def.xml Edgar Link unprocessable
xbit20240331_10q_htm.xml Edgar Link completed